FAM8A1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.2527000000403E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.220700E-03 |
Normal-vs-Stage2 |
1.587590E-01 |
Normal-vs-Stage3 |
4.41800000028358E-07 |
Normal-vs-Stage4 |
1.23800000251251E-08 |
Stage1-vs-Stage2 |
8.286000E-01 |
Stage1-vs-Stage3 |
4.201400E-03 |
Stage1-vs-Stage4 |
1.246220E-04 |
Stage2-vs-Stage3 |
2.461200E-01 |
Stage2-vs-Stage4 |
9.705900E-02 |
Stage3-vs-Stage4 |
3.451200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
6.05329999999737E-05 |
Normal-vs-AfricanAmerican |
1.3908999951795E-08 |
Normal-vs-Asian |
4.236200E-02 |
Caucasian-vs-AfricanAmerican |
3.082300E-03 |
Caucasian-vs-Asian |
7.311000E-01 |
AfricanAmerican-vs-Asian |
5.060800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.72760000030736E-07 |
Normal-vs-Female |
1.582490E-02 |
Male-vs-Female |
1.923930E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.37479999999346E-05 |
Normal-vs-Age(41-60Yrs) |
4.696400E-03 |
Normal-vs-Age(61-80Yrs) |
7.72020000039397E-07 |
Normal-vs-Age(81-100Yrs) |
2.991700E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.654100E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.090200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.284400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.150840E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.142800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.120600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.652000E-01 |
Normal-vs-Grade 2 |
1.900190E-01 |
Normal-vs-Grade 3 |
1.75329999962948E-07 |
Normal-vs-Grade 4 |
1.62847513252018E-12 |
Grade 1-vs-Grade 2 |
3.265800E-01 |
Grade 1-vs-Grade 3 |
5.324200E-03 |
Grade 1-vs-Grade 4 |
1.42629999999588E-06 |
Grade 2-vs-Grade 3 |
2.969800E-04 |
Grade 2-vs-Grade 4 |
1.55979673621687E-11 |
Grade 3-vs-Grade 4 |
2.46530000003187E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
7.392000E-01 |
Normal-vs-ccB subtype |
1.4969003814258E-10 |
ccA subtype-vs-ccB subtype |
4.47010206627851E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.392400E-04 |
Normal-vs-N1 |
3.17179999997919E-06 |
N0-vs-N1 |
5.074300E-02 |
|
|